50 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
and healthy environment for our directors, members of management and stockholders who wish to attend the Annual Meeting. You will be able to attend … business environment, as well as the commitment required to serve as our Chairman, particularly as the board of directors’ oversight responsibilities
8-K
EX-10.1
8imruk deta
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
zi5 nqw5eqiev
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-10.1
1cvr4omq
23 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.2
nl28sg
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
kmahbv
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
DEFA14A
tvn0p95a 5ef7wdgs
7 Apr 22
Additional proxy soliciting materials
4:00pm
8-K
EX-10.1
fys n06nxzt
16 Mar 22
Axcella Therapeutics Announces $25 Million Registered Direct Offering of Common Stock Priced At the Market
8:30am
424B5
ta4 n87gx
16 Mar 22
Prospectus supplement for primary offering
8:00am